Watch: Paediatric Nutrition with Peptamen Junior 1.5 with Kathryn Simpson
- 22/10/2021
Video description
Kathyrn Simpson, Paediatric Dietitian, worked with 8 of her families for the acceptability and tolerance study for Peptamen Junior 1.5. Hear about Kathryn’s experience of being involved in the trial and in particular, learn about two children who took part. Case study 1 focuses on a 6 year old girl with complex TOF and OA. Case study 2 is an 8 year old girl with Cockayne Syndrome.
Information for Healthcare Professional Use Only
In this video, paediatric dietitian, Kathryn Simpson, discusses her positive experiences with Peptamen Junior 1.5 oral nutritional supplement in a clinical trial involving paediatric patients.
Highlights of the video include:
- Overview of an acceptability and tolerability trial for the Peptamen Junior 1.5 supplement, aiming to improve patient feeding tolerance and weight gain.1
- Case studies of trial participants showed significant benefits, including increased oral intake and decreased reliance on tube feeding for patients with complex medical needs.
- Eight families participated in the trial demonstrating patient acceptance, no adverse gastrointestinal symptoms, and improved quality of life.
- Families expressed eagerness for the product’s availability, highlighting its potential to transform nutritional support for children.
Acceptability and tolerability trials are an important step in demonstrating clinical effectiveness and safety of products for enteral nutrition.
Reference:
1. Néstle Health Science Data on File. 2021. Peptamen Junior 1.5kcal/ml ONS Acceptability and Tolerance Study
Footnote: Peptamen Junior 1.5 is a Food for Special Medical Purposes for the dietary management of disease related malnutrition in patients with malabsorption and/or maldigestion. Must be used under medical supervision.